Angiodynamics ANGO
NASDAQ ANGO
$11.89 +0.08 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

Angiodynamics (ANGO) EBIT Margin (2010 - 2026)

Updated

Angiodynamics (ANGO) recorded EBIT Margin of -9.02% in fiscal Q1 2027 (quarter ended Aug 31, 2026), up 5.05 percentage points from -14.07% a year earlier and up 2.75 percentage points from the prior quarter.

Analysis

Angiodynamics (ANGO) EBIT Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Angiodynamics' EBIT Margin came in at -11.24% as of Aug 31, 2026, up 1.23 percentage points year-over-year; for FY2026 (ended May 31, 2026), it came in at -12.47%, up 1.19 percentage points from FY2025.

  • Annual EBIT Margin has a five-year change of -0.35 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, EBIT Margin came in at -13.66% in FY2025 (+49.66 pp), -63.32% in FY2024 (-48.21 pp), -15.11% in FY2023 (-6.11 pp) and -9.00% in FY2022 (+3.12 pp).
  • Quarterly EBIT Margin has ranged from -265.88% in fiscal Q3 2024 to 44.52% in fiscal Q1 2024 over the past five years.
  • On a year-over-year basis, EBIT Margin rose in six of the last eight quarters, with an average year-over-year change of +34.65 percentage points.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 252.03 percentage points in fiscal Q3 2025, against a drop of 254.82 percentage points in fiscal Q3 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -11.77% (Q4 2026), -16.51% (Q3 2026) and -7.71% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 13.44%
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 33.60%
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 18.08%
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 25.18%
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 21.65%
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 29.48%
10 Angiodynamics 499.01 Mn 331.73 Mn 48.04 Mn -9.02%
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 -9.02%
May 31, 2026 -11.77%
Feb 28, 2026 -16.51%
Nov 30, 2025 -7.71%
Aug 31, 2025 -14.07%
May 31, 2025 -7.22%
Feb 28, 2025 -13.85%
Nov 30, 2024 -15.23%
Aug 31, 2024 -19.41%
May 31, 2024 -20.36%
Feb 29, 2024 -265.88%
Nov 30, 2023 -16.59%
Aug 31, 2023 44.52%
May 31, 2023 -22.88%
Feb 28, 2023 -11.06%
Nov 30, 2022 -9.50%
Aug 31, 2022 -16.31%
May 31, 2022 -7.35%
Feb 28, 2022 -7.16%
Nov 30, 2021 -11.09%
API Access

Angiodynamics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ANGO&period=max&api_key=YOUR_API_KEY